NGM Biopharmaceuticals (NGM) – Management Comments
-
NGM Biopharmaceuticals (NGM) Begins Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120
-
NGM Biopharmaceuticals (NGM) Highlights Phase 1 Safety and Pharmacokinetics Data for NGM621 in Patients with Geographic Atrophy
-
-
-
-
-
Back to NGM Stock Lookup